TL Genomics

Koganei, Japan

TL Genomics is a developer of a prenatal diagnosis technology created to isolate fetal nucleated red blood cells in maternal blood.

NaN

Mar 2026

Grant

Top Investors

Shizuoka FundSupportSMBC Venture CapitalNissay CapitalNEDODBJ Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are TL Genomics's investors?

TL Genomics's investors include Shizuoka FundSupport, SMBC Venture Capital, Nissay Capital, NEDO, DBJ Capital.

Where is TL Genomics headquartered?

TL Genomics is headquartered in Koganei, Japan.

What does TL Genomics do?

TL Genomics is a developer of a prenatal diagnosis technology created to isolate fetal nucleated red blood cells in maternal blood.

What stage is TL Genomics at?

TL Genomics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 17, 2026.

MLA

"TL Genomics — Funding & Investors." VCBacked, March 17, 2026, https://www.vcbacked.co/company/tl-genomics. Accessed June 4, 2026.

APA

VCBacked. (2026). TL Genomics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/tl-genomics

Wikipedia (cite web)

{{cite web |title=TL Genomics — Funding & Investors |url=https://www.vcbacked.co/company/tl-genomics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 17, 2026.